(600518)"Kangmei Pharmaceutical Co., Ltd."Announcement on Progress in Repurchasing Shares
Filed with SSE · Stock code 600518 · · 2 pages · Chinese
Summary by 6ix AI
Kangmei Pharmaceutical Co., Ltd has announced the progress of its share repurchase plan.
Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries
On 6ix: 6ix.com/news/600518kangmei-pharmaceutical-co-ltdannouncement-on-progress-in-repurchasing-shares
Kangmei Pharmaceutical Co., Ltd on 6ix
Story so far
- (600518)"Kangmei Pharmaceutical Co., Ltd."Announcement on Progress of Litigation Involved (III)
- (600518)"Kangmei Pharmaceutical Co., Ltd."Announcement on Resolutions of the 8th Extraordinary Meeting of the 10th Board of Directors in 2026
- (600518)"Kangmei Pharmaceutical Co., Ltd."Announcement on Share Repurchase Plan through Call Auction
Earlier from Kangmei Pharmaceutical
- (600518)"Kangmei Pharmaceutical Co., Ltd."Announcement on Progress of Litigation Involved (III)
- (600518)"Kangmei Pharmaceutical Co., Ltd."Announcement on Share Repurchase Plan through Call Auction
- (600518)"Kangmei Pharmaceutical Co., Ltd."Announcement on Resolutions of the 8th Extraordinary Meeting of the 10th Board of Directors in 2026
- Announcement on Resolutions of the 6th Extraordinary Meeting of the 10th Board of Directors in 2026
- Announcement on Convening the 2026 Semi-annual Performance Briefing
Follow Kangmei Pharmaceutical into a list and get an email when it puts out news.
Follow Kangmei Pharmaceutical